EPS8 Antikörper (AA 251-350) (Biotin)
-
- Target Alle EPS8 Antikörper anzeigen
- EPS8 (Epidermal Growth Factor Receptor Pathway Substrate 8 (EPS8))
-
Bindungsspezifität
- AA 251-350
-
Reaktivität
- Human, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser EPS8 Antikörper ist konjugiert mit Biotin
-
Applikation
- ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))
- Kreuzreaktivität
- Human, Ratte
- Homologie
- Mouse,Dog,Cow,Pig,Horse,Guinea Pig
- Aufreinigung
- Purified by Protein A.
- Immunogen
- KLH conjugated synthetic peptide derived from human EPS8
- Isotyp
- IgG
- Top Product
- Discover our top product EPS8 Primärantikörper
-
-
- Applikationshinweise
-
IHC-P 1:200-400
IHC-F 1:100-500 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 μg/μL
- Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C for 12 months.
- Haltbarkeit
- 12 months
-
- Target
- EPS8 (Epidermal Growth Factor Receptor Pathway Substrate 8 (EPS8))
- Andere Bezeichnung
- EPS8 (EPS8 Produkte)
- Synonyme
- AW261790 antikoerper, MGC81285 antikoerper, MGC146320 antikoerper, zgc:56041 antikoerper, epidermal growth factor receptor pathway substrate 8 antikoerper, epidermal growth factor receptor pathway substrate 8 L homeolog antikoerper, EPS8 antikoerper, Eps8 antikoerper, eps8.L antikoerper, eps8 antikoerper
- Hintergrund
-
Synonyms: DFNB102, Epidermal growth factor receptor kinase substrate 8, EPS8
Background: Signaling adapter that controls various cellular protrusions by regulating actin cytoskeleton dynamics and architecture. Depending on its association with other signal transducers, can regulate different processes. Together with SOS1 and ABI1, forms a trimeric complex that participates in transduction of signals from Ras to Rac by activating the Rac-specific guanine nucleotide exchange factor (GEF) activity. Acts as a direct regulator of actin dynamics by binding actin filaments and has both barbed-end actin filament capping and actin bundling activities depending on the context. Displays barbed-end actin capping activity when associated with ABI1, thereby regulating actin-based motility process: capping activity is auto-inhibited and inhibition is relieved upon ABI1 interaction. Also shows actin bundling activity when associated with BAIAP2, enhancing BAIAP2-dependent membrane extensions and promoting filopodial protrusions. Involved in the regulation of processes such as axonal filopodia growth, stereocilia length, dendritic cell migration and cancer cell migration and invasion. Acts as a regulator of axonal filopodia formation in neurons: in the absence of neurotrophic factors, negatively regulates axonal filopodia formation via actin-capping activity. In contrast, it is phosphorylated in the presence of BDNF leading to inhibition of its actin-capping activity and stimulation of filopodia formation. Component of a complex with DFNB31 and MYO15A that localizes at stereocilia tips and is required for elongation of the stereocilia actin core. Indirectly involved in cell cycle progression, its degradation following ubiquitination being required during G2 phase to promote cell shape changes.
- Gen-ID
- 2059
- UniProt
- Q12929
- Pathways
- EGFR Signaling Pathway, Regulation of Actin Filament Polymerization
-